NEO Forward P/E

As of 2025-05-21, the Forward P/E of Neogenomics Inc (NEO) is 43.78.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.